Literature DB >> 10968718

Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands.

N van den Braak1, A Ott, A van Belkum, J A Kluytmans, J G Koeleman, L Spanjaard, A Voss, A J Weersink, C M Vandenbroucke-Grauls, A G Buiting, H A Verbrugh, H P Endtz.   

Abstract

OBJECTIVE: To determine the prevalence and determinants of fecal carriage of vancomycin-resistant enterococci (VRE) in intensive care unit (ICU), hematology-oncology, and hemodialysis patients in The Netherlands.
DESIGN: Descriptive, multicenter study, with yearly 1-week point-prevalence assessments between 1995 and 1998. POPULATION: All patients hospitalized on the testing days in ICUs and hematology-oncology wards in nine hospitals in The Netherlands were included.
METHODS: Rectal swabs obtained from 1,112 patients were screened for enterococci in a selective broth and subcultured on selective media with and without 6 mg/L vancomycin. Resistance genotypes were determined by polymerase chain reaction. Further characterization of VRE strains was done by pulsed-field gel electrophoresis (PFGE). We studied possible determinants of VRE colonization with a logistic regression analysis model. Determinants analyzed included gender, age, and log-transformed length of prior hospital stay.
RESULTS: The results showed that 614 (55%) of 1,112 patients were colonized with vancomycin-sensitive enterococci, and 15 (1.4%) of 1,112 carried VRE. No increase in VRE colonization was observed from 1995 to 1998. Eleven strains were identified as Enterococcus faecium and four as Enterococcus faecalis. All E faecium and one E faecalis carried the vanA gene; the other E faecalis strains harbored the vanB gene. PFGE revealed that three vanB VRE isolated from patients hospitalized in one single ICU were related, suggesting nosocomial transmission. Though higher age seemed associated with VRE colonization, exclusion of patients with the nosocomial strain from the regression analysis decreased this relation to nonsignificant. Duration of hospital stay was not associated with VRE colonization.
CONCLUSION: VRE colonization in Dutch hospitals is an infrequent phenomenon. Although nosocomial spread occurs, most observed cases were unrelated, which suggests the possibility of VRE acquisition from outside the hospital. Prolonged hospital stay, age, and gender proved unrelated to VRE colonization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968718     DOI: 10.1086/501797

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  10 in total

1.  Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type.

Authors:  E M Mascini; K P Jalink; T E M Kamp-Hopmans; H E M Blok; J Verhoef; M J M Bonten; A Troelstra
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 2.  A review of the current place of glycopeptides in turkish medical practice.

Authors:  Hakan Erdem; Oral Oncul
Journal:  Curr Ther Res Clin Exp       Date:  2007-01

3.  Convenient selective differential broth for isolation of vancomycin-resistant enterococcus from fecal material.

Authors:  Thomas J Novicki; Jeffrey M Schapiro; Bruce K Ulness; Ann Sebeste; Laurel Busse-Johnston; Kristine M Swanson; Susan R Swanzy; Wendy Leisenring; Ajit P Limaye
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

4.  Incidence and risk factors of infection caused by vancomycin-resistant enterococcus colonization in neurosurgical intensive care unit patients.

Authors:  Young-Bem Se; Hyoung-Joon Chun; Hyeong-Joong Yi; Dong-Won Kim; Yong Ko; Suck-Jun Oh
Journal:  J Korean Neurosurg Soc       Date:  2009-08-31

Review 5.  Vancomycin: pharmacokinetics and administration regimens in neonates.

Authors:  Matthijs de Hoog; Johan W Mouton; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  Selective decontamination of the digestive tract: all questions answered?

Authors:  Marc J M Bonten; Hans C A Joore; Bartelt M de Jongh; Jan Kluytmans; Ed J Kuijper; Henk J van Leeuwen; Anne Marie G A de Smet; Christina Vandenbroucke-Grauls
Journal:  Crit Care       Date:  2003-01-24       Impact factor: 9.097

7.  Development and evaluation of a Quadruplex Taq Man real-time PCR assay for simultaneous detection of clinical isolates of Enterococcus faecalis, Enterococcus faecium and their vanA and vanB genotypes.

Authors:  Taghi Naserpour Farivar; Reza Najafipour; Pouran Johari; Masoumeh Aslanimehr; Amir Peymani; Hoasan Jahani Hashemi; Baman Mirzaui
Journal:  Iran J Microbiol       Date:  2014-10

8.  Vancomycin-resistant Enterococcus faecium COLONIZATION and Clostridium difficile infection in a HEMATOLOGIC patient.

Authors:  Ivana Goić-Barišić; Marina Radić; Anita Novak; Žana Rubić; Nataša Boban; Boris Lukšić; Marija Tonkić
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780

9.  Detection of both vanA & vanB genes in vanA phenotypes of Enterococci by Taq Man RT-PCR.

Authors:  Bahman Mirzaei; Ryhane Babaei; Akbar Pour Dadash Asiabar; Zakaria Bameri
Journal:  Braz J Microbiol       Date:  2015-03-01       Impact factor: 2.476

10.  Epidemiology of Extended-Spectrum β-Lactamase-Producing E. coli and Vancomycin-Resistant Enterococci in the Northern Dutch-German Cross-Border Region.

Authors:  Xuewei Zhou; Silvia García-Cobos; Gijs J H M Ruijs; Greetje A Kampinga; Jan P Arends; Dirk M Borst; Lieke V Möller; Nicole D Holman; Theo A Schuurs; Lesla E Bruijnesteijn van Coppenraet; Jan F Weel; Jan H van Zeijl; Robin Köck; John W A Rossen; Alexander W Friedrich
Journal:  Front Microbiol       Date:  2017-10-05       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.